5th Neurological Biomarkers Conference

Hits:1738   Date: 1/26/2016

5th Neurological Biomarkers Conference

Organizer: GTCbio

Start date: March 21st, 2016

End date: March 23rd, 2016

The 5th Neurological Biomarkers Conference is one of three conferences part of the Biomarker Summit 2016 to be held on March 21-23, 2016 in San Diego, CA at the Westin San Diego Hotel. This conference focuses on the development of CNS biomarkers for drugs and diagnostics from CSF and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative disorders will be presented on disease areas such as Alzheimer's, Parkinson's and Huntington's. Biomarker challenges for neuropsychiatric disorders such as autism, schizophrenia, depression and mood disorder will also be explored.

I. Imaging Approaches in CNS Drug Discovery & Development
II. CSF & Blood Based Biomarker Approaches
III. Developments in Neurological & Neurodegenerative Disorders
IV. Biomarker Development in Neuropsychiatric Disorders

General Session:
 I. Plenary Keynote Session
 II. Big Data Analytics for Biomarker Development
 III. Novel Technologies in Biomarker Development
 IV. Overcoming Challenges of Clinical Validation & Translation
 V. Panel Discussion: Companion Diagnostics Development & Partnering Strategies
 VI. Panel Discussion: Non-profits & Patient Perspectives on Precision Medicine
 VII. Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development

Session Topics:
 I. Imaging Approaches in CNS Drug Discovery & Development
 II. CSF & Blood Based Biomarker Approaches
 III. Developments in Neurological & Neurodegenerative Disorders
 IV. Biomarker Development in Neuropsychiatric Disorders

Keynote Speaker/ Featured:
 • Sudhir Srivastava, Chief, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH
 • Allen Roses, Jefferson-Pilot Distinguished Professor, Neurobiology & Neurology, Duke University Medical Center
 • Andrew Schade, Senior Director, Clinical Diagnostics Laboratory, Eli Lilly
 • Claudio Carini, Global Head, Clinical Immunology & Biomarkers, Pfizer
 • Jean-François Martini, Senior Director, Translational Oncology Early Development, Pfizer

Venue:  The Westin San Diego

Location (city and country):  San Diego, CA, USA

Event Website:  https://www.gtcbio.com/conferences/neurological-biomarkers-overview  

Submit Abstract Link:  https://www.gtcbio.com/submit-an-abstract/neurological-biomarkers

Contact person in case we need more information:
Name: Janel Lee
Email: janel.lee@gtcbio.com
Phone: 626-256-6405